Ghasem Hosseini Salekdeh

Ghasem Hosseini Salekdeh

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2002 in Proteomics
Verified
Journal Article
Closed access
PDF file
GSGhasem Hosseini Salekdeh
Ghasem Hosseini Salekdeh
JSJoel Siopongco
Joel Siopongco
LWLeonard J. Wade
Leonard J. Wade
BGBehzad Ghareyazie
Behzad Ghareyazie
JBJohn Bennett
John Bennett

1 September 2017 in Pharmacology & Therapeutics
Verified
Journal Article
Open access
KBKyunghee Byun
Kyunghee Byun
YYYongCheol Yoo
YongCheol Yoo
MSMyeongjoo Son
Myeongjoo Son
JLJaesuk Lee
Jaesuk Lee
GJGoo-Bo Jeong
Goo-Bo Jeong
Bonghee LeeBonghee Lee
Bonghee Lee
Advanced glycation end products (AGEs) and their receptor have been implicated in the progressions of many intractable diseases, such as diabetes and atherosclerosis, and are also critical for pathologic changes in chronic degenerative diseases, such as Alzheimer's disease, Parkinson's disease, and alcoholic brain damage. Recently activated macrophages were found to be a source of AGEs, and the most abundant form of AGEs, AGE-albumin excreted by macrophages has been implicated in these diseases and to act through common pathways. AGEs inhibition has been shown to prevent the pathogenesis of AGEs-related diseases in human, and therapeutic advances have resulted in several agents that prevent their adverse effects. Recently, anti-inflammatory molecules that inhibit AGEs have been shown to be good candidates for ameliorating diabetic complications as well as degenerative diseases. This review was undertaken to present, discuss, and clarify current understanding regarding AGEs formation in association with macrophages, different diseases, therapeutic and diagnostic strategy and links with RAGE inhibition.

1 July 2011 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
PLPierre Legrain
Pierre Legrain
RARuedi Aebersold
Ruedi Aebersold
AAAlexander Archakov
Alexander Archakov
ABAmos Bairoch
Amos Bairoch
KBKumar Bala
Kumar Bala
GOGilbert S. Omenn
Gilbert S. Omenn
After the successful completion of the Human Genome Project, the Human Proteome Organization has recently officially launched a global Human Proteome Project (HPP), which is designed to map the entire human protein set. Given the lack of protein-level evidence for about 30% of the estimated 20,300 protein-coding genes, a systematic global effort will be necessary to achieve this goal with respect to protein abundance, distribution, subcellular localization, interaction with other biomolecules, and functions at specific time points. As a general experimental strategy, HPP research groups will use the three working pillars for HPP: mass spectrometry, antibody capture, and bioinformatics tools and knowledge bases. The HPP participants will take advantage of the output and cross-analyses from the ongoing Human Proteome Organization initiatives and a chromosome-centric protein mapping strategy, termed C-HPP, with which many national teams are currently engaged. In addition, numerous biologically driven and disease-oriented projects will be stimulated and facilitated by the HPP. Timely planning with proper governance of HPP will deliver a protein parts list, reagents, and tools for protein studies and analyses, and a stronger basis for personalized medicine. The Human Proteome Organization urges each national research funding agency and the scientific community at large to identify their preferred pathways to participate in aspects of this highly promising project in a HPP consortium of funders and investigators.

1 January 2011 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
MZMaryam Ghayeb Zamharir
Maryam Ghayeb Zamharir
MMMohsen Mardi
Mohsen Mardi
SASeyed Mohammad Alavi
Seyed Mohammad Alavi
NHNader Hasanzadeh
Nader Hasanzadeh
MNMojtaba Khayyam Nekouei
Mojtaba Khayyam Nekouei
GSGhasem Hosseini Salekdeh
Ghasem Hosseini Salekdeh
Background: "CandidatusPhytoplasma aurantifolia", is the causative agent of witches' broom disease in Mexican lime trees (Citrus aurantifoliaL.), and is responsible for major losses of Mexican lime trees in Southern Iran and Oman. The pathogen is strictly biotrophic, and thus is completely dependent on living host cells for its survival. The molecular basis of compatibility and disease development in this system is poorly understood. Therefore, we have applied a cDNA- amplified fragment length polymorphism (AFLP) approach to analyze gene expression in Mexican lime trees infected by "Ca. Phytoplasma aurantifolia".Results: We carried out cDNA-AFLP analysis on grafted infected Mexican lime trees of the susceptible cultivar at the representative symptoms stage. Selective amplifications with 43 primer combinations allowed the visualisation of 55 transcript-derived fragments that were expressed differentially between infected and non-infected leaves. We sequenced 51 fragments, 36 of which were identified as lime tree transcripts after homology searching. Of the 36 genes, 70.5% were down-regulated during infection and could be classified into various functional groups. We showed that Mexican lime tree genes that were homologous to known resistance genes tended to be repressed in response to infection. These included the genes for modifier of snc1 and autophagy protein 5. Furthermore, down-regulation of genes involved in metabolism, transcription, transport and cytoskeleton was observed, which included the genes for formin, importin β 3, transducin, L-asparaginase, glycerophosphoryl diester phosphodiesterase, and RNA polymerase β. In contrast, genes that encoded a proline-rich protein, ubiquitin-protein ligase, phosphatidyl glycerol specific phospholipase C-like, and serine/threonine-protein kinase were up-regulated during the infection.Conclusion: The present study identifies a number of candidate genes that might be involved in the interaction of Mexican lime trees with "CandidatusPhytoplasma aurantifolia". These results should help to elucidate the molecular basis of the infection process and to identify genes that could be targeted to increase plant resistance and inhibit the growth and reproduction of the pathogen.

9 March 2005 in Proteomics
Verified
Journal Article
Closed access
PDF file
MHMohsen Hajheidari
Mohsen Hajheidari
MAMohammad Abdollahian‐Noghabi
Mohammad Abdollahian‐Noghabi
HAHossein Askari
Hossein Askari
MHManzar Heidari
Manzar Heidari
SSSeyed Y. Sadeghian
Seyed Y. Sadeghian
GSGhasem Hosseini Salekdeh
Ghasem Hosseini Salekdeh

1 July 2002 in Field Crops Research
Verified
Journal Article
Closed access
GSGhasem Hosseini Salekdeh
Ghasem Hosseini Salekdeh
JSJ. Siopongco
J. Siopongco
LWLen J. Wade
Len J. Wade
BGB. Ghareyazie
B. Ghareyazie
JBJ. Bennett
J. Bennett